| SOLENO THERAPEUTICS |
| USA |
| Gesundheit |
| US8342033094 / A3DS0P |
| 6XC (Frankfurt) / SLNO (NASDAQ) |
| FRA:6XC, ETR:6XC, 6XC:GR, NASDAQ:SLNO |
| - |
| https://soleno.life/ |
|
Soleno Therapeutics Inc. is a biopharmaceutical co..
>Volltext.. |
| 2185.91 Mio. EUR |
| 1806.42 Mio. EUR |
| 85.68 Mio. EUR |
| -71.43 Mio. EUR |
| -68.12 Mio. EUR |
| -1.59 EUR |
| 45.73 Mio. EUR |
| 214.18 Mio. EUR |
| -22.54 Mio. EUR |
| 15 |
| - |
| 43.25% |
| - |
| - |
| - |
| - |
| SOLENO |
| 07.11.25 |